Glucose metabolic dysfunction in subjects with a clinical dementia rating of 0.5.

J Neurol Sci

Department of Radiology and Nuclear Medicine, Hyogo Brain and Heart Center, 520 Saisho-Ko, Hyogo 670-0981, Himeji, Japan.

Published: November 2003

Objective: To investigate the cerebral glucose metabolism of subjects who had a Clinical Dementia Rating (CDR) of 0.5, we studied 40 subjects whose CDR was 0.5 and 40 age-matched healthy subjects.

Methods: Cerebral glucose image of each subject was obtained by [18F]-2-fluoro-deoxy-D-glucose (FDG) positron emission tomography (PET). The anatomically standardized images were produced with NEUROSTAT. Then, the two groups were compared with the Statistical Parametric Mappings (SPM) 99.

Results: A comparison with the SPM 99 revealed that relative cerebral glucose metabolism was lower in the posterior cingulate gyri and parietal lobules in the CDR 0.5 group than in the healthy subjects group.

Conclusion: These findings are very similar to those in patients with probable Alzheimer's disease (AD) and suggest that the majority of subjects with CDR 0.5 are suffering from very mild AD or at least a prodromal state of AD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-510x(03)00206-5DOI Listing

Publication Analysis

Top Keywords

cerebral glucose
12
subjects clinical
8
clinical dementia
8
dementia rating
8
glucose metabolism
8
subjects cdr
8
subjects
5
glucose
4
glucose metabolic
4
metabolic dysfunction
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!